Digiliti Money Group (OTCMKTS: DGLT) and Affymetrix (NASDAQ:AFFX) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for Digiliti Money Group and Affymetrix, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digiliti Money Group 0 0 1 0 3.00
Affymetrix 0 0 0 0 N/A

Digiliti Money Group currently has a consensus price target of $6.00, indicating a potential upside of 3,900.00%. Given Digiliti Money Group’s higher probable upside, research analysts plainly believe Digiliti Money Group is more favorable than Affymetrix.

Insider & Institutional Ownership

11.3% of Digiliti Money Group shares are held by institutional investors. 50.9% of Digiliti Money Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Digiliti Money Group and Affymetrix’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Digiliti Money Group $7.97 million 0.19 -$15.16 million N/A N/A
Affymetrix N/A N/A N/A $0.12 116.75

Affymetrix has lower revenue, but higher earnings than Digiliti Money Group.


This table compares Digiliti Money Group and Affymetrix’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Digiliti Money Group -147.73% N/A -199.21%
Affymetrix 4.24% 4.84% 2.97%


Digiliti Money Group beats Affymetrix on 5 of the 8 factors compared between the two stocks.

About Digiliti Money Group

Digiliti Money Group, Inc., formerly Digiliti Money, Inc., is a technology solutions and services provider to the financial services industry. The Company’s solutions and services enable its clients, such as banks, credit unions and alternative financial services providers (AFS) to offer their customers remote deposit capture (RDC) and prepaid mobile money technologies and related services. It offers RDC products for businesses and consumers; mobile money management products for consumers, and training and support services for its financial services industry customers. The RDC products are offered to banks and credit unions in the United States, Canada and Latin America. Its mobile money management products are offered to traditional financial institutions (FIs), as well as AFS in the United States, Canada and Latin America. These FIs and AFS providers include banks, credit unions, prepaid card issuers, check cashers and payday lenders.

About Affymetrix

Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

Receive News & Ratings for Digiliti Money Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digiliti Money Group and related companies with Analyst Ratings Network's FREE daily email newsletter.